Symbol: |
TMEM141
|
Description: |
transmembrane protein 141 [Source:HGNC Symbol;Acc:28211]
|
Location: |
Chr9:139685807-139695010[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:228
Gene |
Compound |
Gen_sig |
Exp_pattern |
TMEM141 |
NSC 37031 |
0.027 |
Up |
TMEM141 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.001 |
Up |
TMEM141 |
Maxima isoflavone D |
0.027 |
Up |
TMEM141 |
Phenol, 2,2'-methylenebis[5-chloro- |
0.023 |
Up |
TMEM141 |
C.I. 37559 |
0.007 |
Up |
TMEM141 |
NSC 58903 |
0.009 |
Up |
TMEM141 |
9-AC |
0.03 |
Up |
TMEM141 |
NSC 604979 |
0.026 |
Up |
TMEM141 |
RAPAMYCIN PRODRUG |
0.023 |
Up |
TMEM141 |
Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- |
0.021 |
Up |
TMEM141 |
Benzoic acid, 2-hydroxy-, (2,6-pyridinediyldiethylidyne)dihydrazide, manganese chloride complex |
0.04 |
Up |
TMEM141 |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.036 |
Up |
TMEM141 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.008 |
Up |
TMEM141 |
2-Propen-1-one, 3-(l,3-benzodioxol-5-yl)-1-(1,4-dioxo- 2,6,7-trimethylquinoxalin-3-yl)- |
0.003 |
Up |
TMEM141 |
1-Naphthalenecarboxamide, N,N'-1,8-(octanediyl)bis- |
0.003 |
Up |
Expression pattern: Sensitivity / Resistance
Total:16 Current:3
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:14
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|